1. Home
  2. NEUE vs QNCX Comparison

NEUE vs QNCX Comparison

Compare NEUE & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • QNCX
  • Stock Information
  • Founded
  • NEUE 2015
  • QNCX 2012
  • Country
  • NEUE United States
  • QNCX United States
  • Employees
  • NEUE N/A
  • QNCX N/A
  • Industry
  • NEUE
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NEUE
  • QNCX Health Care
  • Exchange
  • NEUE NYSE
  • QNCX Nasdaq
  • Market Cap
  • NEUE 41.6M
  • QNCX 34.4M
  • IPO Year
  • NEUE 2021
  • QNCX 2019
  • Fundamental
  • Price
  • NEUE $5.00
  • QNCX $1.78
  • Analyst Decision
  • NEUE Hold
  • QNCX Strong Buy
  • Analyst Count
  • NEUE 1
  • QNCX 3
  • Target Price
  • NEUE $8.00
  • QNCX $9.67
  • AVG Volume (30 Days)
  • NEUE 8.7K
  • QNCX 1.4M
  • Earning Date
  • NEUE 11-07-2024
  • QNCX 11-13-2024
  • Dividend Yield
  • NEUE N/A
  • QNCX N/A
  • EPS Growth
  • NEUE N/A
  • QNCX N/A
  • EPS
  • NEUE N/A
  • QNCX N/A
  • Revenue
  • NEUE $996,890,000.00
  • QNCX N/A
  • Revenue This Year
  • NEUE N/A
  • QNCX N/A
  • Revenue Next Year
  • NEUE $10.49
  • QNCX N/A
  • P/E Ratio
  • NEUE $1.47
  • QNCX N/A
  • Revenue Growth
  • NEUE N/A
  • QNCX N/A
  • 52 Week Low
  • NEUE $4.66
  • QNCX $0.51
  • 52 Week High
  • NEUE $16.59
  • QNCX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 46.19
  • QNCX 67.44
  • Support Level
  • NEUE $4.66
  • QNCX $1.56
  • Resistance Level
  • NEUE $5.24
  • QNCX $1.76
  • Average True Range (ATR)
  • NEUE 0.34
  • QNCX 0.26
  • MACD
  • NEUE -0.01
  • QNCX 0.03
  • Stochastic Oscillator
  • NEUE 39.53
  • QNCX 67.54

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: